Diffusion-weighted imaging in predicting and monitoring the response of uterine cervical cancer to combined chemoradiation

Clinical Radiology

Volumn 64, Issue 11, 2009, Pages 1067-1074

  Liu, Y ^a   Bai, R ^a   Sun, H ^a   Liu, H ^b   Zhao, X ^a   Li, Y ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Tianjin Central Hospital of Obstetrics and Gynecology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SIZE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TREATMENT DURATION; TREATMENT RESPONSE; UTERINE CERVIX CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CISPLATIN; COMBINED MODALITY THERAPY; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 70349750180     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crad.2009.07.010     Document Type: Article

References (22)

1. Jeong Y.Y., Kang H.K., Chung T.W., et al. Uterine cervical carcinoma after therapy: CT and MR imaging findings. RadioGraphics 23 (2003) 969
2. Sahdev A., Sohaib S.A., Wenaden A.E., et al. The performance of magnetic resonance imaging in early cervical carcinoma: a long-term experience. Int J Gynecol Cancer 17 (2007) 629
3. Engin G. Cervical cancer: MR imaging findings before, during, and after radiation therapy. Eur Radiol 16 (2006) 313
4. Kaur H., Silverman P.M., Iyer R.B., et al. Diagnosis, staging, and surveillance of cervical carcinoma. AJR Am J Roentgenol 180 (2003) 1621
5. Flueckiger F., Ebner F., Poschauko H., et al. Cervical cancer: serial MR imaging before and after primary radiation therapy-a 2-year follow-up study. Radiology 184 (1992) 89
6. Hricak H., Swift P.S., Campos Z., et al. Irradiation of the cervix uteri: value of unenhanced and contrast-enhanced MR imaging. Radiology 189 (1993) 381
7. Kinkel K., Ariche M., Tardivon A.A., et al. Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging. Radiology 204 (1997) 55
8. Koh D.M., Scurr E., Collins D., et al. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. AJR Am J Roentgenol 188 (2007) 1001
9. Ross B.D., Moffat B.A., Lawrence T.S., et al. Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol Cancer Ther 2 (2003) 581
10. Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92 (2000) 205
11. Ohara K., Tanaka Y., Tsunoda H., et al. Assessment of cervical cancer radioresponse by serum squamous cell carcinoma antigen and magnetic resonance imaging. Obstet Gynecol 100 (2002) 781
12. Thoeny H.C., De Keyzer F., Chen F., et al. Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats. Radiology 234 (2005) 756
13. Chenevert T.L., Stegman L.D., Taylor J.M., et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 92 (2000) 2029
14. Jennings D., Hatton B.N., Guo J., et al. Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI. Neoplasia 4 (2002) 255
15. Mardor Y., Roth Y., Lidar Z., et al. Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging. Cancer Res 61 (2001) 4971
16. Dzik-Jurasz A., Domenig C., George M., et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 360 (2002) 307
17. Hein P.A., Kremser C., Judmaier W., et al. Diffusion-weighted MRI-a new parameter for advanced rectal carcinoma?. Rofo 175 (2003) 381 [in German]
18. Chen C.Y., Li C.W., Kuo Y.T., et al. Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants-initial experience. Radiology 239 (2006) 448
19. Koh D.M., and Collins D.J. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 188 (2007) 1622
20. Roth Y., Tichler T., Kostenich G., et al. High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice. Radiology 232 (2004) 685
21. Moffat B.A., Chenevert T.L., Lawrence T.S., et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci USA 102 (2005) 5524
22. Moffat B.A., Hall D.E., Stojanovska J., et al. Diffusion imaging for evaluation of tumor therapies in preclinical animal models. MAGMA 17 (2004) 249